Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients.
Zhang H, Jin R, Yao C, Zhang T, Wang M, Xia W, Peng H, Wang X, Lu R, Wang C, Xie D, Wu H.
Zhang H, et al. Among authors: wang x, wang m, wang c.
AIDS Res Ther. 2016 Feb 10;13:8. doi: 10.1186/s12981-016-0091-1. eCollection 2016.
AIDS Res Ther. 2016.
PMID: 26865854
Free PMC article.
Clinical Trial.